STOCK TITAN

Director Douglas Hudson exits Allurion Technologies (ALUR) board role

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Allurion Technologies, Inc. reported that director Douglas Hudson, a Class II member of the board, resigned from the board and from the Nominating and Corporate Governance Committee effective June 30, 2026. The company stated that his resignation was not due to any disagreement with management, the board, or company policies or practices. The board is evaluating which current director will be appointed to replace him on the Nominating and Corporate Governance Committee.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Resignation effective date June 30, 2026 Douglas Hudson’s board and committee resignation
8-K signature date July 1, 2026 Signed by Legal Officer Brendan M. Gibbons
Common stock par value $0.0001 per share Allurion Technologies common stock
Warrant exercise price $3,037.50 per share Exercise price for ALUR WS warrants
Warrant share ratio 0.00378787 shares per warrant Each ALUR WS warrant’s underlying common stock
Emerging growth company regulatory
"Emerging growth company Item 5.02 Departure of Directors"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Class II member of the board financial
"Douglas Hudson, a Class II member of the board of directors"
Nominating and Corporate Governance Committee financial
"position on the Nominating and Corporate Governance Committee of the Board"
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
par value financial
"Common stock, par value $0.0001 per share"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
warrants financial
"Warrants to purchase 0.00378787 shares of common stock"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Allurion Technologies (ALUR) disclose in this 8-K filing?

Allurion Technologies disclosed that director Douglas Hudson resigned from its board and Nominating and Corporate Governance Committee effective June 30, 2026. The company noted his resignation was not due to any disagreement with management, the board, or the company’s operations, policies, or practices.

When did Allurion director Douglas Hudson’s resignation become effective?

Douglas Hudson’s resignation from Allurion’s board became effective on June 30, 2026. On that date, he stepped down as a Class II director and from the Nominating and Corporate Governance Committee, according to the company’s current report filed under Item 5.02.

How will Allurion Technologies fill the Nominating and Corporate Governance Committee seat?

Allurion Technologies said its board is evaluating which of its current directors will replace Douglas Hudson on the Nominating and Corporate Governance Committee. The filing does not yet name a successor, only indicating that the board is considering alternatives internally.

Who signed the Allurion Technologies 8-K reporting the director resignation?

The 8-K was signed on July 1, 2026, by Brendan M. Gibbons, identified as the company’s Legal Officer. His signature indicates the filing was duly authorized on behalf of Allurion Technologies under the Securities Exchange Act of 1934 requirements.

What securities of Allurion Technologies are listed in this disclosure?

The disclosure lists Allurion’s common stock with a par value of $0.0001 per share under the symbol ALUR, and warrants trading as ALUR WS. Each warrant is exercisable for 0.00378787 shares of common stock at an exercise price of $3,037.50 per share.
false0001964979NONENONE0001964979alur:WarrantsToPurchase000378787SharesOfCommonStockEachAtAnExercisePriceOf303750PerShareOfCommonStockMember2026-06-302026-06-300001964979alur:CommonStockParValue00001PerShareMember2026-06-302026-06-3000019649792026-06-302026-06-30

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 30, 2026

 

 

Allurion Technologies, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-41767

92-2182207

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

11 Huron Drive

 

Natick, Massachusetts

 

01760

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (508) 647-4000

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common stock, par value $0.0001 per share

 

ALUR

 

N/A

Warrants to purchase 0.00378787 shares of common stock, each at an exercise price of $3,037.50 per share of common stock

 

ALUR WS

 

N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 30, 2026, Douglas Hudson, a Class II member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and position on the Nominating and Corporate Governance Committee of the Board, effective the same day. Mr. Hudson's resignation was not the result of any disagreement with management or the Board or on any matter relating to the Company’s operations, policies or practices.

The Board is currently evaluating which of its directors will replace Mr. Hudson on the Nominating and Corporate Goverance Committee.

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

Date:

July 1, 2026

By:

/s/ Brendan M. Gibbons

 

 

 

Name: Brendan M. Gibbons

Title:Chief Legal Officer

 


Filing Exhibits & Attachments

1 document